Hold, sell, buy?
Profit fell 53% as expenses ramped up prior to revenue benefits. EPS of 19c missed estimates of 43c; revenue of $155.9M missed estimates of $161.5M. EBITDA was $21.6M vs estimates $34.7M. Net loans at $459.8M were better than expected ($452.9M). Revenue guidance for 2026 matched estimates (at the midpoint of the guided range). Revenue rose 21% in the quarter but EBITDA fell 32%. Provisions rose as the softness seen in the Q3 extended into Q4. Not great results here, but the stock has been very weak already leading into the print. HOLD, and we will where things settle today.